Photodynamic/ photothermal therapy enhances neutrophil-mediated ibrutinib tumor delivery for potent tumor immunotherapy: More than one plus one?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Photodynamic/ photothermal therapy enhances neutrophil-mediated ibrutinib tumor delivery for potent tumor immunotherapy: More than one plus one?
Authors
Keywords
Neutrophil-mediated drug-delivery system, Photodynamic/photothermal therapy, Ibrutinib, T-cell immune responses, Immunotherapy
Journal
BIOMATERIALS
Volume 269, Issue -, Pages 120652
Publisher
Elsevier BV
Online
2021-01-08
DOI
10.1016/j.biomaterials.2021.120652
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma
- (2020) Yunfeng Gao et al. Nature Biomedical Engineering
- Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy
- (2019) Qiujun Qiu et al. Acta Biomaterialia
- Tumor Reoxygenation and Blood Perfusion Enhanced Photodynamic Therapy using Ultrathin Graphdiyne Oxide Nanosheets
- (2019) Yucai Wang et al. NANO LETTERS
- Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment
- (2019) Ling Hu et al. PHARMACEUTICAL RESEARCH
- Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy
- (2019) Cheng Xu et al. ACS Nano
- Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway
- (2019) Dechun Liu et al. NANO LETTERS
- Targeted delivery of pixantrone to neutrophils by poly(sialic acid)- p -octadecylamine conjugate modified liposomes with improved antitumor activity
- (2018) Xiang Luo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Novel Self-Assembled Ibrutinib-Phospholipid Complex for Potently Peroral Delivery of Poorly Soluble Drugs with pH-Dependent Solubility
- (2018) Qiujun Qiu et al. AAPS PHARMSCITECH
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway
- (2017) K Kondo et al. LEUKEMIA
- Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
- (2017) Jingwei Xue et al. Nature Nanotechnology
- Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
- (2016) Andrew Stiff et al. CANCER RESEARCH
- Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
- (2016) Zijian Zhou et al. CHEMICAL SOCIETY REVIEWS
- The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma
- (2016) M. Ruella et al. CLINICAL CANCER RESEARCH
- Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy
- (2016) Dafeng Chu et al. Advanced Healthcare Materials
- Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
- (2015) Idit Sagiv-Barfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- Reactive Oxygen Species in Inflammation and Tissue Injury
- (2013) Manish Mittal et al. ANTIOXIDANTS & REDOX SIGNALING
- Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
- (2013) J. A. Dubovsky et al. BLOOD
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PDT-induced inflammatory and host responses
- (2011) Małgorzata Firczuk et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Neutrophils, from Marrow to Microbes
- (2010) Niels Borregaard IMMUNITY
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neutrophil kinetics in health and disease
- (2010) Charlotte Summers et al. TRENDS IN IMMUNOLOGY
- Reactive Oxygen Species Regulate Neutrophil Recruitment and Survival in Pneumococcal Pneumonia
- (2008) Helen M. Marriott et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP
- (2008) B. Heit et al. JOURNAL OF CELL SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now